DH Definitive Healthcare Corp.companySEC Filings & Insider Trading Activity 2026
Latest Definitive Healthcare Corp. (DH) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 26, 2026, a 10-Q quarterly report filed on November 6, 2025, an 8-K current report filed on April 9, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Definitive Healthcare Corp. (DH) (SEC CIK 1861795), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Risk Factors
- • Regulatory/legal risk: Sales tax liabilities from prior misclassification of products and services, now addressed by voluntary disclosures and registrations to avoid future penalties
- • Macroeconomic/geopolitical risk: Customer churn, particularly in Life Sciences market, driven by macroeconomic headwinds and international trade/tariff uncertainties impacting spending
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-09-30)
Risk Factors
- • New goodwill impairment risk triggered by Q1 2025 market cap decline, resulted in $176.5 million non-cash charge
- • Sales execution risk materially updated due to 2024 restructuring plan disrupting sales, impacting customer acquisition and renewal rates in 2025
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 2.02: Results of Operations and Financial Condition
- • Q4 or full-year 2025 earnings release filed Feb 26, 2026, signed by CFO Casey Heller
- • No financial figures included in this filing section — refer to the attached press release exhibit for key metrics
Annual Reports Archive10-K
AI-powered analysis of Definitive Healthcare Corp. (DH) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of Definitive Healthcare Corp. (DH) 10-Q quarterly reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Definitive Healthcare Corp. (DH) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | — | $251.4M | $252.2M | $241.5M |
| Gross Profit | $180.0M | $203.9M | $197.5M | $183.3M |
| Operating Income | — | -$329.8M | -$710.8M | -$224.3M |
| Net Income | — | -$202.4M | -$413.1M | -$138.9M |
| Gross Margin | — | 81.1% | 78.3% | 75.9% |
| Op. Margin | — | -131.2% | -281.8% | -92.9% |
| Net Margin | — | -80.5% | -163.8% | -57.5% |
| Balance Sheet | ||||
| Total Assets | — | $1.8B | $1.1B | $735.5M |
| Equity | $1.5B | $1.2B | $607.2M | $379.0M |
| ROE | — | -16.9% | -68.0% | -36.7% |
Source: XBRL financial data from Definitive Healthcare Corp. (DH) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 9, 2026 | — | — | — |
8-K | Apr 3, 2026 | — | — | — |
10-K | Feb 26, 2026 | Dec 31, 2025 | Analysis | |
8-K | Feb 26, 2026 | — | Analysis | — |
10-Q | Nov 6, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Aug 7, 2025 | Jun 30, 2025 | — | |
10-Q | May 8, 2025 | Mar 31, 2025 | — | |
10-K | Feb 27, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 7, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 5, 2024 | Jun 30, 2024 | — | |
10-Q | May 7, 2024 | Mar 31, 2024 | — | |
10-K | Feb 28, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 2, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 14, 2023 | Jun 30, 2023 | — | |
10-Q | May 4, 2023 | Mar 31, 2023 | — | |
10-K | Feb 27, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 3, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 4, 2022 | Jun 30, 2022 | — | |
10-Q | May 5, 2022 | Mar 31, 2022 | — | |
10-K | Mar 15, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 8, 2021 | Sep 30, 2021 | — |
Frequently Asked Questions
What are the latest DH SEC filings in 2026?
Definitive Healthcare Corp. (DH) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 6, 2025, an 8-K current report on April 9, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did DH file its most recent 10-K annual report?
Definitive Healthcare Corp. (DH) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view DH 10-Q quarterly reports?
Definitive Healthcare Corp. (DH)'s most recent 10-Q quarterly report was filed on November 6, 2025. SignalX displays every DH 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has DH filed recently?
Definitive Healthcare Corp. (DH)'s most recent 8-K was filed on April 9, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find DH insider trading activity (Form 4)?
SignalX aggregates every DH Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does DH file with the SEC?
Definitive Healthcare Corp. (DH) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new DH filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Definitive Healthcare Corp. (DH).
What is DH's SEC CIK number?
Definitive Healthcare Corp. (DH)'s SEC CIK (Central Index Key) number is 1861795. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1861795 to look up all DH filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find DH return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Definitive Healthcare Corp. (DH) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Definitive Healthcare Corp. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 21+ filings.